Battle against Preeclampsia: Where Do We Stand Today?
Rebecca Khan, MD, FACOG
Lab-developed, FDA-cleared assays that use validated biomarkers could help detect and manage preeclampsia
Rebecca Khan, MD, FACOG
Rebecca Khan, MD, FACOG, practiced obstetrics and gynecology for 21 years before serving as the director of women’s health for BioReference® Laboratories, LLC. Currently, Khan works in medical affairs at Thermo Fisher Scientific with a focus on placental biomarkers, sFlt-1 and PlGF.